Taniguchi, Takashi <br/><br/>
Fibrosis, vascular activation, and immune abnormalities resembling systemic sclerosis in bleomycin-treated Fli-1-haploinsufficient mice.  [electronic resource] 

 -  Arthritis & rheumatology (Hoboken, N.J.)  Feb 2015 
 - 517-26 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2326-5205 
<br/><br/><label>Standard No.: </label>10.1002/art.38948  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Bleomycin--adverse effects<br/>Cell Movement--physiology<br/>Cytokines--metabolism<br/>Disease Models, Animal<br/>Endothelium, Vascular--pathology<br/>Epithelial-Mesenchymal Transition--physiology<br/>Female<br/>Fibrosis<br/>Haploinsufficiency--genetics<br/>Immune System--pathology<br/>Integrins--metabolism<br/>Macrophages--pathology<br/>Mast Cells--pathology<br/>Mice<br/>Mice, Inbred C57BL<br/>Mice, Mutant Strains<br/>Proto-Oncogene Protein c-fli-1--deficiency<br/>Scleroderma, Systemic--chemically induced<br/>Skin--metabolism<br/>Transforming Growth Factor beta--metabolism